• OPEN AN ACCOUNT
Indian Indices
Sensex
81,287.19 -961.42
( -1.17%)
Global Indices
Nasdaq
48,844.08 -676.12
(-1.37%)
Dow Jones
6,870.91 -58.95
(-0.85%)
Hang Seng
58,843.60 90.21
(0.15%)
Nikkei 225
10,926.32 79.62
(0.73%)
Forex
USD-INR
90.93 0.01
(0.01%)
EUR-INR
107.33 0.10
(0.10%)
GBP-INR
122.97 -0.01
(-0.01%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Kopran Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524280
INE082A01010
86.2115334
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KOPRAN
31.38
634.96
EPS(TTM)
Face Value()
Div & Yield %
4.19
10
2.28
 

Ugro Capital board nod to raise Rs 100-cr via NCDs
Nov 19,2025
The company will issue up to 1 Lakh listed, rated, senior, secured, transferable, redeemable, NCDs, each having face value of Rs 10,000, aggregating up to Rs 100 crore. It has also has the option to retain oversubscription up to 1 lakh NCDs, aggregating up to Rs 100 crore.

The NCDs carry a tenure of 15 months from the deemed date of allotment and will mature on 27 February 2027. Investors will receive interest at 9.50% per annum, disbursed every month.

Ugro Capital is a pioneering DataTech NBFC specializing in MSME and small business financing. By leveraging advanced data analytics and an extensive distribution network, it bridges the vast small business credit gap in India, delivering tailored credit solutions to micro, small, and medium enterprises (MSMEs) across the country.

The company’s standalone net profit increased 21.9% to Rs 43.31 crore on 34.5% jump in total income to Rs 461.18 crore in Q2 FY26 compared with Q2 FY25.

The scrip declined 1.73% to Rs 182 on the BSE.